Align Technology (NASDAQ:ALGN) reported Q2 EPS of $2.00, $0.28 worse than the analyst estimate of $2.28. Revenue for the quarter came in at $969.6 million versus the consensus...
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Technology, Oil & Gas and Telecoms sectors propelled shares higher. At the close in NYSE, the Dow...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
July was a good month for stocks—but the good news was nuanced. At the top of the list, the S&P 500 finished July up 2.28%, its sixth monthly gain in a row. The Dow Jones...
Align Technology, Inc. is a global medical device company. The Company is engaged in the design, manufacture and marketing of Invisalign clear aligners, iTero intraoral scanners and services for dentistry, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for dental laboratories and dental practitioners. It operates through two segments: Clear Aligner, and Systems and Services. Its Clear Aligner segment consists of Comprehensive Products, which includes Invisalign Comprehensive and Invisalign First; Non-Comprehensive Products, which includes Invisalign Moderate, Lite and Express packages and Invisalign Go and Invisalign Go Plus, and Non-Case products, which include retention products, Invisalign training, adjusting tools used by dental professionals during the course of treatment and consumer products that are complementary to its doctor-prescribed principal products. Its Systems and Services segment consists of its iTero intraoral scanning systems.
|Average||350.27 (+63.51% Upside)|
|No. of Analysts||14|